NO972068L - Farmasöytisk sammensetning basert på stabiliserte lipofile matriser for kontrollert frigiving av aktive prinsipper - Google Patents

Farmasöytisk sammensetning basert på stabiliserte lipofile matriser for kontrollert frigiving av aktive prinsipper

Info

Publication number
NO972068L
NO972068L NO972068A NO972068A NO972068L NO 972068 L NO972068 L NO 972068L NO 972068 A NO972068 A NO 972068A NO 972068 A NO972068 A NO 972068A NO 972068 L NO972068 L NO 972068L
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
controlled release
composition based
active principles
lipophilic matrices
Prior art date
Application number
NO972068A
Other languages
English (en)
Other versions
NO972068D0 (no
NO318227B1 (no
Inventor
Gilles Fonknechten
Patrick Genty
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO972068D0 publication Critical patent/NO972068D0/no
Publication of NO972068L publication Critical patent/NO972068L/no
Publication of NO318227B1 publication Critical patent/NO318227B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19972068A 1996-05-06 1997-05-05 Stabilisert lipofil matrise for kontrollert frigiving av aktive prinsipper, farmasoytisk sammensetning inneholdende det samme og fremgangsmate for fremstilling av disse. NO318227B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9605606A FR2748209B1 (fr) 1996-05-06 1996-05-06 Composition pharmaceutique a base de matrices lipophiles stabilisees pour la liberation controlee de principes actifs

Publications (3)

Publication Number Publication Date
NO972068D0 NO972068D0 (no) 1997-05-05
NO972068L true NO972068L (no) 1997-11-07
NO318227B1 NO318227B1 (no) 2005-02-21

Family

ID=9491845

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19972068A NO318227B1 (no) 1996-05-06 1997-05-05 Stabilisert lipofil matrise for kontrollert frigiving av aktive prinsipper, farmasoytisk sammensetning inneholdende det samme og fremgangsmate for fremstilling av disse.

Country Status (16)

Country Link
EP (1) EP0806202B1 (no)
JP (1) JP3983339B2 (no)
CN (1) CN1171270A (no)
AT (1) ATE212543T1 (no)
AU (1) AU720146B2 (no)
CA (1) CA2204475C (no)
DE (1) DE69710121T2 (no)
DK (1) DK0806202T3 (no)
ES (1) ES2170922T3 (no)
FR (1) FR2748209B1 (no)
HU (1) HU222045B1 (no)
NO (1) NO318227B1 (no)
NZ (1) NZ314740A (no)
PL (1) PL190562B1 (no)
PT (1) PT806202E (no)
ZA (1) ZA973836B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011363A3 (fr) * 1997-09-11 1999-08-03 Smb Technology Capsules semi-solides autoemulsionnables matricielles a action prolongee.
FR2782006B1 (fr) * 1998-08-07 2002-04-19 Gattefosse Ets Sa Composition a liberation prolongee apte a former une micro-emulsion
DE10161078A1 (de) * 2001-12-12 2003-08-28 Achim Goepferich Matrizes zur Stabilisierung und kontrollierten Freisetzung von Problemarzneistoffen
ATE424187T1 (de) * 2002-07-15 2009-03-15 Alcon Inc Bioerodierbare folie zur abgabe eines ophthalmischen arzneimittels
AU2004264958B2 (en) 2003-08-13 2010-04-15 Biocon, Ltd Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
GB0324574D0 (en) * 2003-10-21 2003-11-26 Glaxo Group Ltd Novel compositions
CA2627292C (en) 2005-10-26 2012-04-17 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
CN101351196B (zh) * 2005-10-26 2013-07-03 班纳制药公司 作为胶囊填充物的基于亲脂性载体的双重控释基质系统
US8198268B2 (en) 2008-10-31 2012-06-12 Janssen Biotech, Inc. Tianeptine sulfate salt forms and methods of making and using the same
JP2013119540A (ja) * 2011-12-08 2013-06-17 Nipro Corp 固形医薬組成物およびその製造法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797286A (en) * 1985-11-12 1989-01-10 Eli Lilly And Company Orally administerable sustained release pharmaceutical formulations
DE4413350A1 (de) * 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
US5545628A (en) * 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate

Also Published As

Publication number Publication date
JPH1045629A (ja) 1998-02-17
AU1999197A (en) 1997-11-13
HUP9700842A1 (hu) 1998-08-28
EP0806202B1 (fr) 2002-01-30
ATE212543T1 (de) 2002-02-15
DK0806202T3 (da) 2002-05-06
HU222045B1 (hu) 2003-04-28
DE69710121T2 (de) 2002-11-28
CA2204475C (fr) 2002-12-03
ZA973836B (en) 1997-12-02
CA2204475A1 (fr) 1997-11-06
FR2748209B1 (fr) 1998-06-05
PL319808A1 (en) 1997-11-10
NO972068D0 (no) 1997-05-05
PL190562B1 (pl) 2005-12-30
CN1171270A (zh) 1998-01-28
AU720146B2 (en) 2000-05-25
FR2748209A1 (fr) 1997-11-07
JP3983339B2 (ja) 2007-09-26
NZ314740A (en) 1998-11-25
ES2170922T3 (es) 2002-08-16
NO318227B1 (no) 2005-02-21
EP0806202A1 (fr) 1997-11-12
PT806202E (pt) 2002-06-28
HU9700842D0 (en) 1997-06-30
DE69710121D1 (de) 2002-03-14

Similar Documents

Publication Publication Date Title
EP0350246A3 (en) Sustained release microcapsule for water soluble drug
DE59310399D1 (de) Prodrugs, ihre Herstellung und Verwendung als Arzneimittel
FR2653338B1 (fr) Formulation pour des pansements a liberation prolongee de medicament et son utilisation.
ES2201644T3 (es) Composicion farmaceutica a base de estrogeno y de progesterona.
PT83872A (de) Arzneimittel
AU651894B2 (en) Matrix tablet permitting the sustained release of indapamide after oral administration
DE69426382D1 (de) Bioadhesive pharmazeutische Zusammensetzung zur kontrollierten Freigabe von Wirkstoffen
FR2680109B1 (fr) Composition pour la liberation prolongee et controlee et controlee d'une substance medicamenteuse peptidique et procede pour sa preparation.
DE69307977D1 (de) Stabilisierte Derivate von Vitamin D2 und D3 enthaltende pharmazeutische Zusammensetzungen
DE69626386D1 (de) Verpackungsmaterial mit aktiver auslösung
NO972068D0 (no) Farmasöytisk sammensetning basert på stabiliserte lipofile matriser for kontrollert frigiving av aktive prinsipper
DE59804823D1 (de) Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
FI891865A7 (fi) Atselastiinia sisältäviä lääkkeitä, joista vaikuttava aine vapautuu säädellysti
HUT75029A (en) Systems for controlled release of pilocarpine, and semipermeable capsule containing the active ingredient
HUT50787A (en) Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
ATE80797T1 (de) Hemizellulosematrix enthaltende arzneizubereitungen mit verzoegerter freisetzung.
DE69318153D1 (de) Antihypercholesterämisch-wirksame verbindungen, pharmazeutische präparate und verwendungen davon
DE69012031D1 (de) Optisch aktive Benzylalkoholverbindung und pharmazeutische Zusammensetzung.
GB2246072B (en) Solid pharmaceutical compositions containing a light sensitive active ingred ient and stabilised by a dye
ATA124091A (de) Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz
HUT47205A (en) Stabilized solid insecticides containing as active substance s,s'-(2)dimethyl-amin(-trimethilen-)bis-(benzosulphonate)
DE58905106D1 (de) Neue 1,2-dithiol-3-thion-s-oxid-verbindungen enthaltende arzneimittel.
NO170282C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,4-diazepinderivater
DE68902056D1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
ATE175870T1 (de) Pharmazeutische zubereitung zur rektalen verabreichung von pharmakologisch wirksamen verbindungen

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees